Duvall Diantha
Insider CIK 1696784 · CRIS CFO · GNCA CHIEF FINANCIAL OFFICER · BIVV Chief Accounting Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRIS CURIS INC | A Award deriv | 2026-07-07 | 2026-07-09 | 48,285 | $5.29 | $255.4K | 48,285 | SEC↗ |
| CRIS CURIS INC | C Conversion deriv | 2026-03-20 | 2026-03-23 | 50 | — | $0 | 0 | SEC↗ |
| CRIS CURIS INC | C Conversion | 2026-03-20 | 2026-03-23 | 66,666 | — | $0 | 77,707 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2026-03-17 | 2026-03-18 | 50 | — | $0 | 50 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2026-03-17 | 2026-03-18 | 66,666 | — | $0 | 66,666 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2026-03-17 | 2026-03-18 | 66,666 | — | $0 | 66,666 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2026-03-17 | 2026-03-18 | 66,666 | — | $0 | 66,666 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2025-05-20 | 2025-05-22 | 135,000 | $3.13 | $422.6K | 135,000 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2025-01-28 | 2025-01-30 | 15,000 | $3.13 | $47.0K | 15,000 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2024-05-21 | 2024-05-23 | 39,000 | $11.62 | $453.2K | 39,000 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2023-01-20 | 2023-01-24 | 500,000 | — | $0 | 500,000 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | S Sale | 2022-06-02 | 2022-06-03 | 1,355 | $0.06 | $81 | 75,388 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | S Sale | 2022-05-26 | 2022-05-26 | 24,407 | $0.08 | $2.0K | 76,743 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | S Sale | 2022-04-04 | 2022-04-05 | 963 | $1.25 | $1.2K | 91,775 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | S Sale | 2022-03-16 | 2022-03-17 | 2,873 | $1.10 | $3.2K | 92,738 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award deriv | 2022-03-15 | 2022-03-17 | 112,500 | — | $0 | 112,500 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award | 2022-03-15 | 2022-03-17 | 37,500 | — | $0 | 95,611 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award deriv | 2021-03-15 | 2021-03-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award deriv | 2021-03-15 | 2021-03-17 | 112,500 | — | $0 | 112,500 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award | 2021-03-15 | 2021-03-17 | 37,500 | — | $0 | 37,500 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award deriv | 2020-06-01 | 2020-06-02 | 24,938 | — | $0 | 24,938 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award | 2020-06-01 | 2020-06-02 | 6,623 | — | $0 | 6,623 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award deriv | 2020-04-02 | 2020-04-06 | 46,313 | — | $0 | 46,313 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award | 2020-04-02 | 2020-04-06 | 12,299 | — | $0 | 12,299 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award deriv | 2019-03-05 | 2019-03-07 | 475,000 | — | $0 | 475,000 | SEC↗ |
| BIVV Bioverativ Inc. | D To issuer deriv | 2018-03-08 | 2018-03-08 | 11,062 | — | $0 | 0 | SEC↗ |
| BIVV Bioverativ Inc. | D To issuer deriv | 2018-03-08 | 2018-03-08 | 7,273 | — | $0 | 0 | SEC↗ |
| BIVV Bioverativ Inc. | D To issuer deriv | 2018-03-08 | 2018-03-08 | 2,780 | — | $0 | 0 | SEC↗ |
| BIVV Bioverativ Inc. | D To issuer deriv | 2018-03-08 | 2018-03-08 | 7,030 | — | $0 | 0 | SEC↗ |
| BIVV Bioverativ Inc. | D To issuer | 2018-03-08 | 2018-03-08 | 2,791 | — | $0 | 0 | SEC↗ |
| BIVV Bioverativ Inc. | F Tax w/h | 2018-03-02 | 2018-03-05 | 105 | $104.73 | $11.0K | 2,791 | SEC↗ |
| BIVV Bioverativ Inc. | F Tax w/h | 2018-02-22 | 2018-02-26 | 168 | $104.30 | $17.5K | 2,896 | SEC↗ |
| BIVV Bioverativ Inc. | M Exercise deriv | 2018-02-14 | 2018-02-15 | 1,390 | — | $0 | 2,780 | SEC↗ |
| BIVV Bioverativ Inc. | F Tax w/h | 2018-02-14 | 2018-02-15 | 454 | $103.52 | $47.0K | 3,064 | SEC↗ |
| BIVV Bioverativ Inc. | M Exercise | 2018-02-14 | 2018-02-15 | 1,390 | — | $0 | 3,518 | SEC↗ |
| BIVV Bioverativ Inc. | A Award deriv | 2018-01-31 | 2018-02-02 | 7,273 | — | $0 | 7,273 | SEC↗ |
| BIVV Bioverativ Inc. | S Sale | 2017-06-28 | 2017-06-29 | 818 | $60.47 | $49.5K | 2,128 | SEC↗ |
| BIVV Bioverativ Inc. | F Tax w/h | 2017-05-02 | 2017-05-03 | 99 | $57.48 | $5.7K | 2,946 | SEC↗ |
| BIVV Bioverativ Inc. | F Tax w/h | 2017-03-02 | 2017-03-03 | 113 | $52.81 | $6.0K | 3,045 | SEC↗ |
| BIVV Bioverativ Inc. | A Award deriv | 2017-02-28 | 2017-03-02 | 7,030 | — | $0 | 7,030 | SEC↗ |
| BIVV Bioverativ Inc. | F Tax w/h | 2017-02-28 | 2017-03-02 | 211 | $47.76 | $10.1K | 3,158 | SEC↗ |
| BIVV Bioverativ Inc. | A Award | 2017-02-28 | 2017-03-02 | 3,360 | — | $0 | 3,369 | SEC↗ |
| BIVV Bioverativ Inc. | A Award deriv | 2017-02-14 | 2017-02-16 | 11,043 | — | $0 | 11,043 | SEC↗ |
| BIVV Bioverativ Inc. | A Award deriv | 2017-02-14 | 2017-02-16 | 4,170 | — | $0 | 4,170 | SEC↗ |
| BIVV Bioverativ Inc. | A Award deriv | 2017-02-14 | 2017-03-27 | 11,062 | — | $0 | 11,062 | SEC↗ |